NVS
Novartis AG
$123.36
+$0.43(+0.35%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$242.50B
Volume
992.43K
52W Range
$96.06 - $130.46
Target Price
$120.29
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | $89.5B | $95.0B | $97.3B | $51.6B | $50.5B | $45.4B | $50.3B | ||
| Total Revenue | $89.5B | $95.0B | $49.9B | $44.0B | $43.5B | $46.7B | $51.7B | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | $-14.5B | $-14.4B | $-15.1B | $11.7B | $11.6B | $12.5B | $12.8B | ||
| GROSS PROFIT | |||||||||
| Gross Profit | $31.6B | $34.3B | $34.8B | $32.2B | $31.9B | $34.2B | $38.9B | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $24.8B | $27.2B | $26.4B | $-25.3B | $-27.1B | $24.5B | $24.5B | ||
| Research & Development | $8.5B | $9.4B | $9.0B | $9.5B | $10.0B | $11.4B | $10.0B | ||
| Research Expense | $8.5B | $9.4B | $9.0B | -- | -- | $11.4B | $10.0B | ||
| Selling, General & Administrative | $13.7B | $14.4B | $14.2B | $14.9B | $14.3B | $12.5B | $12.6B | ||
| Selling & Marketing Expenses | $13.7B | $14.4B | $14.2B | -- | -- | $12.5B | $12.6B | ||
| General & Administrative Expenses | $16.5B | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-1.0B | -- | -- | -- | -- | -- | -- | ||
| Depreciation & Amortization | -- | $-305.0M | $-330.0M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $472.0M | $-305.0M | $-330.0M | -- | -- | -- | -- | ||
| Other Operating Expenses | $2.6B | $3.4B | $3.2B | $-895.0M | $-2.9B | $610.0M | $1.9B | ||
| OPERATING INCOME | |||||||||
| Operating income | $50.2B | $53.4B | $55.8B | $11.7B | $9.2B | $9.7B | $14.4B | ||
| EBITDA | $15.0B | $9.8B | $17.2B | $30.9B | $14.7B | $9.9B | $14.6B | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | $932.0M | $850.0M | $869.0M | $787.0M | $800.0M | $792.0M | $943.0M | ||
| Interest Income Operating | $142.0M | -- | -- | -- | -- | -- | -- | ||
| Intinc | $292.0M | $245.0M | $91.0M | $71.0M | $379.0M | $219.0M | $145.0M | ||
| Net Non-Operating Interest Income/Expense | $-746.0M | $-805.0M | $-947.0M | $-891.0M | $-633.0M | $-573.0M | $-798.0M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $-184.0M | -- | -- | ||
| Other Income/Expense | $-20.7B | $-2.7B | $-10.5B | $-15.3B | $193.0M | $-227.0M | -- | ||
| Other Special Charges | $14.2B | $2.0B | $1.7B | $1.9B | $805.0M | -- | -- | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | $3.2B | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | $-603.0M | $11.7B | $702.0M | -- | -- | -- | -- | ||
| Impairment of Capital Assets | -- | $-37.0M | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $15.0B | $9.8B | $10.7B | $25.3B | $8.0B | $9.9B | $14.6B | ||
| Pre-Tax Income | $14.1B | $8.9B | $9.9B | $26.1B | $8.4B | $9.1B | $13.6B | ||
| INCOME TAX | |||||||||
| Tax Provision | $-11.5B | $-5.4B | $1.8B | $1.6B | $1.1B | $-551.0M | $1.7B | ||
| NET INCOME | |||||||||
| Net Income | $81.4B | $81.5B | $8.1B | $24.0B | $7.0B | $15.9B | $11.9B | ||
| Net Income (Continuing Operations) | $81.4B | $81.5B | $71.6B | $46.8B | $5.7B | $9.7B | $11.9B | ||
| Net Income (Discontinued Operations) | $81.4B | $81.5B | $8.1B | $24.0B | $7.0B | $15.9B | $11.9B | ||
| Net Income (Common Stockholders) | $81.4B | $81.5B | $8.1B | $24.0B | $7.0B | $15.9B | $11.9B | ||
| Normalized Income | -- | -- | -- | -- | -- | $8.6B | $13.5B | ||
| TOTALS | |||||||||
| Total Expenses | $10.3B | $12.8B | $11.2B | $11.3B | $12.5B | $37.0B | $37.3B | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $2.3B | $2.3B | $2.3B | $2.2B | $1.8B | $2.1B | $2.0B | ||
| Average Shares Outstanding (Diluted) | $17.8B | $16.1B | $20.4B | $11.5B | $1.8B | $2.1B | $2.0B | ||
| Shares Outstanding | $2.3B | $2.3B | $2.3B | $2.2B | $2.1B | $2.0B | $2.0B | ||
| Basic EPS | $5.44 | $5.12 | $3.55 | $10.71 | $3.19 | $7.15 | $5.92 | ||
| Basic EPS (Continuing Operations) | -- | $3.12 | $3.55 | $10.71 | -- | $7.15 | $5.92 | ||
| Diluted EPS | $5.38 | $5.06 | $3.52 | $10.63 | $3.17 | $7.1 | $5.87 | ||
| Diluted EPS (Continuing Operations) | -- | $3.08 | $3.52 | $10.63 | -- | $7.1 | $5.87 | ||
| Dividend Per Share | -- | -- | -- | -- | $3.46 | $3.2 | $3.3 | ||
| OTHER METRICS | |||||||||
| Acquired In Process Rn D | $664.0M | $11.7B | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | -- | -- | $8.1B | -- | -- | -- | -- | ||
| Allowances For Construction | $218.0M | -- | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | $2 | -- | -- | -- | -- | -- | ||
| Depletion | $472.0M | -- | -- | -- | -- | -- | -- | ||
| Development Expense | $167.0M | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | -- | $1.98 | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $6.4B | $659.0M | $673.0M | $15.3B | $-9.0M | $-13.0M | -- | ||
| Earnings From Equity Interest Net Of Tax | $6.4B | $659.0M | $673.0M | $15.3B | $-9.0M | $-13.0M | -- | ||
| Gain On Sale Of Business | -- | $4.7B | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $12.6B | -- | -- | -- | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $-186.0M | $4.6B | -- | -- | -- | -- | -- | ||
| Insurance And Claims | $823.0M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $855.0M | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $3.0M | $5.0M | $1.0M | $3.0M | -- | $-4.0M | $2.0M | ||
| Net Income Discontinuous Operations | $-186.0M | $9.2B | -- | -- | -- | $6.3B | -- | ||
| Other Costof Revenue | -- | -- | -- | -- | -- | $12.5B | $12.8B | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | $4.6B | -- | -- | -- | -- | -- | ||
| Other Gand A | $16.5B | -- | -- | -- | -- | -- | -- | ||
| Realized Capital Gain | $2.4B | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $15.7B | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $13.7B | $14.4B | $14.2B | -- | -- | -- | -- | ||
| Write Down | $603.0M | $-752.0M | $-702.0M | -- | -- | -- | -- | ||
| Restruct | $3.2B | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVS | $123.36 | +0.3% | 992.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |